| Study Period | 2019 - 2032 |
| Market Size in 2024 | USD 2.3 Billion |
| Market Size in 2025 | USD 3.0 Billion |
| Market Size by 2032 | USD 20.3 Billion |
| Projected CAGR | 31.4% |
| Largest Region | North America |
| Fastest Growing Region | APAC |
| Market Structure | Fragmented |
|
Explore the market potential with our data-driven report
The healthcare fraud analytics market size was USD 2.3 billion in 2024, which is predicted to reach USD 20.3 billion by 2032, growing at a CAGR of 31.4% during 2025–2032.
The growth of this market is attributed to the increasing number of people with health insurance, coupled with the rising incidence of fraud in the medical industry. Among the frauds, those related to pharmacy claims have become a significant cause for concern for insurance firms, healthcare providers, as well as governments.
Moreover, the rising incidence of bribery and overcharging for the settlement of health insurance claims and the growing adoption of the prepayment review model create a high demand for such analytics services and software. Further, the growing literacy rate across the world and the high expenditure on health are driving people to opt for insurance. Due to this, the need for solutions that can reduce the chances of fraud, such as biometric sensors (to recognize fraudsters), is driving the market.
Furthermore, developing countries are increasingly adopting such software for detecting wrongdoing. Additionally, the advent of social media and its growing influence on the medical industry, as well as the role of artificial intelligence in fraud detection, will create new opportunities for medical fraud detection solution providers in the coming period. In addition, the increasing government focus on genuine claims scrutiny and enforcement of protective legislations is a key factor for this growth. The healthcare industry has become a major focus for law enforcement agencies due to the large amounts of money involved and the high potential for fraud.
The descriptive analytics category held the largest market share, of 45%, in 2024. This is owed to the ease of usage offered by descriptive analytics solutions and their simplicity of integration into other sources of information, in order to produce expressive insights. Moreover, this type of analytics is frequently adopted for studying the existing as well as historical data for the identification of trends and relationships. Descriptive analytics is increasingly being utilized for assessing various clinical decisions and their consequences on service performance, care quality, and overall patient outcomes.
The predictive analytics category will show the fastest advance during the projection time frame. This technique is used more by healthcare payers for checking for fraudulent activity before paying the claim. Traditional approaches to the detection of fraud, such as manual investigations and audits, have limited speeds, scalability, and accuracy. That is where predictive analytics becomes useful, as it offers a new approach to detecting fraud before it happens. By the employment of statistical modeling, machine learning algorithms, and data mining, predictions about the future are made. This allows users to quickly identify fraudulent activities and take the appropriate action, which, ultimately, helps decrease losses, protect assets, and maintain customers’ trust. These solutions recognize patterns that are possibly fraudulent and then develop some rules to flag certain claims.
The prescriptive analytics category will grow at the highest CAGR during the forecast period, as this approach helps in estimating the cost and benefit of anti-fraud solutions and aids users in organizing patient data to analyze if they are spending more on trying to catch the fraud as compared to what they would be losing if it is carried out.
The solution types analyzed here are:
The on-premise category held the larger market share, of 75%, in 2024. The on-premises approach is reliable and secure, and it allows enterprises to uphold a level of control and ease of access to data, which allows for the better management of records, as well as monitoring of the information.
Moreover, the on-premises setup has been accepted widely by insurance companies to tackle large datasets hospitals have, which include patient history, diagnosis and prescription details, and payment and insurance information. Additionally, companies are accepting this deployment approach because it provides full ownership and control over the software and data, along with comprehensive insights, and aids in taking decisions related to hardware and software.
The on-demand category will grow at the higher CAGR during the forecast period, due to the cost-effectiveness of this approach for any company. This is essentially a B2B model, where the software, hardware, and datasets are maintained by the provider for the company. Additionally, this model offers companies unlimited storage for the massive amounts of patient data, which will only increase with time.
The delivery models analyzed here are:
The insurance claims review category held the largest market share, of 55%, in 2024. This is owed to the growing adoption of health insurance, which, as a downside, results in an increase in the number of fraudulent claims. While performing an insurance claims review, the insurer will try to see whether the medical condition the treatment for which is to be reimbursed is covered by the policy. Both patients and their doctors will need to provide proof it is a genuine claim, and the insurer will need to be certain the claim satisfies the terms and conditions of their insurance policy.
The pharmacy billing issues category will grow at the highest CAGR, of approx. 30%, during the forecast period, owing to the rising number of billing frauds involving drugstores. Many pharmacies produce unauthorized bills and dispense unprescribed drugs. The latter practice has the potential to seriously harm patients, which is why the need to detect such frauds is driving the adoption of appropriate analytics software.
The applications analyzed here are:
The public & government agencies category held the largest market share, of 55%, in 2024. This is because national healthcare programs, such as Medicare and Medicaid, are conducted on a large scale in the U.S., and billions of dollars’ worth of claims are processed through such programs on an annual basis. The rules and regulations of these agencies ensure the authorities identify and stop fraud, waste, and abuse, and advanced analytics provides an essential tool.
Also, the budgets that the public healthcare systems have set aside for compliance and fraud detection provide an opportunity to economically continue making an investment in analytics platforms. They are characterized by huge volumes of claims and face systemic fraud, to which elaborate fraud detection techniques are required.
The private insurance payers category will grow at the highest CAGR, of approx. 35%, during the forecast period. This is because of the rising financial cost of stolen claims to the profitability of private insurance companies. In contrast to the government agencies, the private insurers are competitive in their market, and this factor leads to the fast integration of advanced analytical tools to protect against mistakes and money loss. These companies are quickly switching to AI for real-time fraud detection, to save time and reduce manual checks. Additionally, the fast approach and scalability of using cloud-based and predictive analytics solutions are more possible when the insurer is not a state company.
The end users analyzed here are:
Drive strategic growth with comprehensive market analysis
North America held the largest market share, of 40%, in 2024. This will be due to the high per capita income and healthcare expenditure, vast population of the elderly and patients, large number of people with health insurance, high incidence of healthcare frauds, favorable government initiatives for anti-fraud activity, and pressure to reduce healthcare costs. Moreover, the increase in the number of service providers and technological advancements in software meant to detect such wrongdoing are aiding in the growth of the market in the region.
Moreover, the presence of the corporate headquarters of the majority of the leading players in the healthcare fraud detection market drive the demand for the associated software. For instance, International Business Machines Corporation’s headquarters is located in Armonk, New York.
Furthermore, Canada is showing significant growth in this market due to its advancing healthcare infrastructure, rising number of government initiatives for reducing the incidence of healthcare frauds, and a large population covered by at least one health insurance policy.
Asia-Pacific is the fastest-growing region, with a CAGR of 35%. This growth is driven by expanding healthcare digitization, rising insurance adoption, and an urgent need to combat complex fraud schemes. Countries such as India, China, and Indonesia are witnessing a rise in fraudulent insurance claims, prescription manipulation, and false billing, which is straining public and private health systems. In India alone, healthcare fraud accounts for an estimated 7–10% of total healthcare spending, driven largely by fake hospital admissions and inflated procedure costs.
In China, fraud detection initiatives have intensified following reports of widespread insurance abuse in urban healthcare networks, with authorities recovering hundreds of millions in fraudulent payouts in recent crackdowns. Southeast Asian countries like Thailand and the Philippines have also reported growing losses due to forged prescriptions and claim duplication, prompting insurers to adopt real-time fraud analytics tools. These regional trends highlight a pressing need for advanced analytics solutions tailored to the scale and complexity of fraud challenges emerging across Asia-Pacific's rapidly evolving healthcare landscape.
The regions and countries analyzed in this report are:
The market is fragmented in nature due to the presence of many vendors offering specialized solutions across different fraud types, technologies, and end users. Companies focus on varied approaches, such as rule-based systems, AI/ML, and predictive analytics, creating a diverse landscape. Additionally, the market serves a wide range of customers from public payers to private insurers—each with unique needs, contributing to fragmentation. However, signs of consolidation are emerging as larger players acquire niche firms and integrate capabilities into broader platforms to meet the growing demand for unified, scalable fraud detection solutions.
Want a report tailored exactly to your business need?
Request CustomizationLeading companies across industries trust us to deliver data-driven insights and innovative solutions for their most critical decisions. From data-driven strategies to actionable insights, we empower the decision-makers who shape industries and define the future. From Fortune 500 companies to innovative startups, we are proud to partner with organisations that drive progress in their industries.
Working with P&S Intelligence and their team was an absolute pleasure – their awareness of timelines and commitment to value greatly contributed to our project's success. Eagerly anticipating future collaborations.
McKinsey & Company
India
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws
Customize the Report to Align with Your Business Objectives
Request the Free Sample Pages